Company information lookup

Go

View full list of companies

ACRUX LIMITED (ACR)

A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options 		ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACR 3.850 0% 3.820 3.850 3.870 3.900 3.800 385,280

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

ACRUX LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACR
Securities
Official Listing Date 29 September, 2004
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.acrux.com.au
Registered Office Address 103-113 Stanley Street, WEST MELBOURNE, VIC, AUSTRALIA, 3003
Head Office Telephone (03) 8379 0100
Head Office Fax (03) 8379 0101
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Ross Dobinson (Chairman)
Mr Ross Barrow (Non Exec. Director)
Mr Bruce Parncutt (Non Exec. Director)
Mr Jon Pilcher (CFO)
Company Secretary Mr Jon Pilcher
Principal Activities A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

ACRUX LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.		 Headline Pages PDF
15/05/2013   Becoming a substantial holde rfrom AMP 16 PDF
08/05/2013   Ceasing to be a substantial holder from AMP 11 PDF
26/04/2013 asterix Axiron net sales, quarter to 31 March 2013 1 PDF
22/04/2013   Change in substantial holding 4 PDF
20/03/2013   Becoming a substantial holder 5 PDF
20/03/2013   Change in substantial holding 4 PDF
04/03/2013   Appendix 3B 12 PDF
28/02/2013   Axiron in Australia 4 PDF
18/02/2013   Investor presentation, 18 February 2013 20 PDF
18/02/2013 asterix Acrux provides half-year update 4 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
23 May 2013 3.850 -0.77% 3.900 3.800 385,280
22 May 2013 3.880 0.26% 3.940 3.840 439,216
21 May 2013 3.870 1.04% 3.890 3.770 437,381
20 May 2013 3.830 -1.03% 3.900 3.780 278,073
17 May 2013 3.870 1.31% 3.890 3.770 453,795

* Volume of shares shown represents only those shares traded on ASX.

ACRUX LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

Code Div Amount Ex Div Date Record Date Date Payable % Franked Type Further Information
ACR 8c 04/09/2012 10/09/2012 24/09/2012 0% Final UNFRANKED NIL CFI

Exchange Traded Options

No Exchange Traded Options are available over the security ACR

Warrants & Structured Products

Warrants & Structured Products are available over the security ACR. Click here to view the current warrant issue details.

ASX CFDs

No Contracts For Differences are available over the security ACR